CD4 and Opportunistic infection: Stable patients (aged ≥18 years, on first‐line ART ≥12 months, CD4 count ≥300 cells/mL3, without opportunistic infections, not pregnant/breastfeeding) were eligible for SMCC, with three‐monthly drug refills from community health workers.